<ul class="ProvisionList"><li><p class="Subsection amending"><strong><a class="sectionLabel" id="s-17"><span class="sectionLabel">17</span></a></strong> <a class="lawLabel" id="s-17ss-(1)ID0ECBA"><span class="lawlabel">(1)</span></a> Paragraph 118.2(2)(u) of the Act is replaced by the following:</p><section><div class="AmendedText"><ul class="ProvisionList"><li><p class="Paragraph"><a class="lawLabel" id="s-17ss-(1)AmendedTextSectionPiecep-(u)ID0EBAAABA"><span class="lawlabel">(u)</span></a> on behalf of the patient who is the holder of a <span class="DefinitionRef"><dfn>medical document</dfn></span> (as defined in subsection 264(1) of the <cite class="XRefExternalRegulation"><a href="/eng/regulations/SOR-2018-144">Cannabis Regulations</a></cite>) to support their use of cannabis for medical purposes, for the cost of cannabis, cannabis oil, cannabis plant seeds or cannabis products purchased for medical purposes from a holder of a <span class="DefinitionRef"><dfn>licence for sale</dfn></span> (as defined in subsection 264(1) of the <cite class="XRefExternalRegulation"><a href="/eng/regulations/SOR-2018-144">Cannabis Regulations</a></cite>).</p></li></ul></div></section></li><li><p class="Subsection transitional"><a class="lawLabel" id="s-17ss-(2)ID0EBAA"><span class="lawlabel">(2)</span></a> Subsection (1) is deemed to have come into force on October 17, 2018.</p></li></ul>
